Description
Development, characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-10-01$100,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-10-01(start date) | $100,000 | — | Development, characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epilept… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2024-2025-Q3-00857 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $333,000 | FY2025 |
| 236-2022-2023-Q3-00539 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $761,176 | FY2023 |
| 236-2021-2022-Q4-00024 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $100,000 | FY2022 |
| 236-2020-2021-Q4-00127 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $450,000 | FY2021 |
| 236-2020-2021-Q3-00264 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $612,000 | FY2021 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2018-2019-Q3-00858 · retrieved 2026-11-15.